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Purpose: Osteoarthritis (OA) is a degenerative disease characterized by
the degradation of articular cartilage. Human bone marrow mesen-
chymal stem cells (BM-MSCs) have been presented as candidate cells for
cartilage tissue engineering due to their ability to undergo chondrogenic
differentiation after extensive expansion in vitro and stimulation with
various biomaterials in three-dimensional systems. Hyaluronic acid (HA)
is one of the major components of the hyaline cartilage and plays a key
role in maintaining chondrocytes function. PEPM [poly-(2-ethyl-2-pyr-
rolidone) methacrylate]-HA are semi-interpenetrated (SIPN) networks,
where this biopolymer is integrated as a building block for new
biocompatible therapeutic materials. This study is aimed at analyzing the
chondrogenic potential of BM-MSCs derived from OA patients, cultured
in PEPMHA hydrogels under hypoxia and normoxia environments,
simulating the physiological oxygen tension in cartilaginous regionsĂversus ambient air, respectively, as well as under static and semi-
dynamic conditions.
Methods: Human bone marrow MSCs isolated from OA patients, were
cultured in PEPMHA hydrogels, under hypoxia (5% pO2) or normoxia
environments (21% pO2), under static or semi-dynamic conditions (70
rpm). MSCs- only and chondrocytes (OA and normal) were seeded as
control. After 96 hours, cells’ viability was assessed using the alamar blue
assay. Cell-constructs were thereafter cultured for 21 days in a chondro-
genic differentiation medium, supplemented with the transforming
growth factor-b3 (TGF-b3), dexamethasone and retinoic acid. Histological
examination was performed using hematoxylin-eosin, alcian blue-PAS,
toluidine blue and safranin-O stainings, as well as immunohistochem-
istry analysis of types I, II and X collagen. Cell differentiation was
monitored by real-time PCR (types I, II collagen, aggrecan, MMP13 and
RUNX2). Fig.1
Results: BM- MSCs viability was assessed using the alamar blue assay.
After 96h seeding in PEPMHA hydrogels, under different conditions, cells
metabolic activity was altered although maintaining their viability (Figure
1) and therefore cell culture was performed for a longer period of time to
predict the suitability of this cell-construct for a cartilage tissue engi-
neering approach. After 21 days in a chondrogenic differentiation medium,
cells secreted an extracellular matrix incorporating types I, II collagen and
proteoglycans. Cells in normoxia, both under static or semi-dynamic
conditions, resulted in a more potent differentiation although in some
cases, MSCs were further differentiated to a premature hypertrophic state,
seen by the expression of type X collagen. Cells cultured under hypoxia
have shown a different behaviour, enabling the formation of a more stable
tissue, in the absence of hypertrophy.
Conclusions: MSCs derived from OA patients’ present a limitation for in
vitro chondrogenesis studies due to the imminent induction of a ﬁbro-
cartilaginous tissue. Culture in PEPMHA hydrogels alone was not
sufﬁcient to reverse this differentiation although from our results one
could speculate that hypoxia may delay terminal differentiation of
MSCs.
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Purpose: Therapeutic treatments for articular cartilage repair are
limited and where they exist, such as Autologous Chondrocyte
Implantation (ACI), procedures result in variable outcomes. We
hypothesise that a major factor affecting the outcome of ACI and related
cell-based therapies is the source of cells used. We discovered that
cartilage derived stem cells from normal tissue have a high cellular
proliferative potential, maintain the chondrogenic phenotype in vitro
and demonstrate a restricted differentiation potential, such that they do
not express collagen type X. However, there is also a need to investigate
the biology of cartilage derived stem cells from osteoarthritic (OA)
joints and determine their potential for use in autologous cartilage
repair treatments. This work describes the isolation and character-
isation of OA derived cartilage stem cells.
Methods: Normal and osteoarthritic human cartilage samples were
obtained with relevant ethical approval. Cartilage biopsies were enzy-
matically digested and subjected to differential adhesion to ﬁbronectin.
Colonies generated from a single cell were selected and expanded with
population doubling (PD) data collated at each passage. At PD30 and PD50,
the b galactosidase assay for senescence and the bromodeoxyuridine
incorporation assay (BrDU) for proliferative index were performed on
monolayer cell cultures. Normal and OA derived stem cell lines were
subjected to Single Telomere Length Analysis (STELA) to determine
average telomere length.
Results: The results demonstrate that differential adhesion to ﬁbronectin
allows generation of OA-derived stem cell lines. However, percentages of
